Biogen has promoted its chief commercial officer, Michel Vounatsos, to become its new CEO, taking over from George Scangos. Vounatsos will take over the position from Scangos on 6 January.
Biogen has announced a major revamp of its business that will see chief executive Michel Vounatsos depart the company, and all commercial activities related to troubled Alzheimer's therapy Aduhelm ...